Worldwide mortality from COPD

Long-Term Intervention in Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2004, Pages 37-52

  Muir, Jean FrançOis ^a   Cuvelier, Antoine ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855606246     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (51)

1. Bourier MH, Guideraux M. Mortality from disorders of the respiratory system throughout the world between 1950 and 1972. World Health Stat Q 1979; 32(3):174-197.
2. World Health Statistics Annual 1998, WHO, Geneva.
3. World Health Statistics Annual 1999, WHO, Geneva.
4. Murray CJL, Lopez AD. The Global Burden of Disease and Injury.1. Cambridge, MA: Harvard University Press, 1996.
5. American Thoracic Society. Standards for the diagnosis and care of patients with COPD. Am J Respir Crit Care Med 1995; 152:S77-S120.
6. American Lung Association. COPD. American Lung Association fact sheet, Sept. 1988.
7. Snider GL. Facteurs de risque et populations a` risque. Rev Mal Respir 1998; 15:2S5-2S9.
8. Desideri M, Viegi G, Carrozzi L, Pedreschi M, Pistelli F, Magiorelli F, Fornai E, Paoletti P, Giuntini C. Mortality rates for respiratory disorders in Italy. Monaldi Arch Chest Dis 1997; 52:212-216.
9. Feinleib M, Rosemberg HM, Collins JG, Delozier JE, Pokras R, Chevariey FM. Trends in COPD morbidity and mortality in the United States. Am Rev Respir Dis 1989; 140:S9-S18.
10. Strachan DP. Epidemiology: a British perspective. In: Calverley PM, Pride NB, eds. Chronic Obstructive Pulmonary Disease. London: Chapman & Hall, 1995:47-68.
11. Mannino DM, Brown C, Giovino GA. Obstructive lung disease in the United States from 1979 through 1993. An analysis using multicause mortality data. Am J Respir Crit Care Med 1997; 156:814-818.
12. Thom TJ. International comparisons in COPD mortality. Am Rev Respir Dis 1989; 140:S27-S34.
13. Manfreda J, Mao Y, Litven W. Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:S19-S26.
14. Rijcken B, Britton J. Epidemiology of COPD. Eur Respir Monogr 1998; 7:41-73.
15. Cook DG, Shaper AG. Breathlessness, lung function, and risks of a heart attack. Eur Heart J 1988; 9:1215-1222.
16. Ebi-Kryston AL. Respiratory symptoms and pulmonary function as predictors of 10-years mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Epidemiol Community Health 1986; 41: 251-260.
17. Strachan DP. Ventilatory function as a predictor of fatal stroke. Br Med J 1991; 302:84-87.
18. Annuaire De Statistiques Sanitaires Mondiales, 1995. Organisation Mondiale De Santé, Genève, 1996.
19. Trends in chronic bronchitis and emphysema: Morbidity and Mortality. Epidemiology and Statistics Unit, American Lung Association, New York, September 1996.
20. Cooreman J, Thom TJ, Higgins MW. Mortality from chronic obstructive pulmonary disease and asthma in France, 1969-1983. Comparisons with the US and Canada. Chest 1990; 97:213-219.
21. Higgins MW, Thom T. Incidence, prevalence and mortality: infra- and intercountry differences. In: Hensley MJ, Saunders NA, eds. Clinical Epidemiology of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker, 1989; 23-43.
22. Gulsvik A. Mortality in and prevalence of COPD in different parts of Europe. Monaldi Arch. Chest Dis 1999; 54:160-162.
23. Mortality patterns-United States, 1993. 1996. MMWR 45:161-164.
24. Giovino GA, Schooley MW, Zhu BP, Chrismon JH, Tomar SL, Peddicord JP, Merritt RK, Husten CG, and Eriksen MP. Centers for Disease Control and Prevention-surveillance for selected tobacco-use behaviors-United States, 1900-1994. MMWR C.D.C. Surveill Summ 1994; 43(No. SS-3):l-43.
25. Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:S85-S91.
26. Paoletti P, Carrozzi L, Viegi G, Modena P, Ballerin L, DiPede F, Grado L, Baldacci S, Pedreschi M, Vellutini M. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking and level of pulmonary function. Am J Respir Crit Care Med 1995; 151:1770-1777.
27. Sherrill DL, Holberg CJ, Enright PL, Lebowitz MD, Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149:591-597.
28. Mannino DM, Ford E, Giovino GA, Thun M. Lung cancer deaths in the United States from 1979 through 1992: an analysis using multiple-cause mortality data (abst). Am Rev Respir Dis 1996; 153: A658.
29. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use. N Engl J Med 1994; 330:907-912.
30. Lacasse Y, Brooks D, Goldstein RS, and Rehabilitation Committee of the Canadian Thoracic Society. Trends in epidemiology of COPD in Canada, 1980 to 1995. Chest 1999; 116:306-313.
31. Tai Hing Lam, Yao He, Lan Sun Li, Liang Shou Li, Shu Fang He, Bao Qing Liang. Mortality attributable to cigarette smoking in China. JAMA 1997; 278:1505-1508.
32. Peto R, Lopezs DA, Boreham J, Thun M, Heath C Jr. Mortality from Smoking in Developed Countries 1950-2000 Oxford, England: Oxford University Press, 1994, pp. 35-55.
33. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA 1996; 275:1646-1650.
34. Wu XG, Wan SY, He JS. A prospective study on risk factors of coronary heart disease in male workers in Beijing Capital Steel Company: relationship between blood pressure, serum cholesterol, smoking, and coronary heart disease. Chin Circ J 1991; 6:127-130.
35. Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
36. Aelvoet W, Komitzer M, DeBacker G. Gezondheidsindicatoren 1997. Flemish Ministry of Public Health 1999.
37. Giuntini C, Paoletti P. Epidemiologia delle malattie polmonari in Italia. Aggiorn Med 1983; 3:333-339.
38. Siafakas NM, Vermeire P, Pride NB, Parletti P, Gibson J, Howard P, Yernault JC, Decramen M, Higenbottam T, Postman DL on behalf of the ERS Task Force. Optimal assessment and management of COPD. Eur Respir J 1995; 8:1398-1420.
39. Lung and Asthma Information Agency. Trends in asthma mortality in the elderly. New York, 1992; 92/1.
40. Pharmametrics. DIP-Base Disease segment: subcategories of chronic bronchitis 1994; (suppl):1-18. www.pharmiq.com.
41. Pharmametrics DIP-Base. Disease segment: COPD. 1994; 1:44-70. www.pharmiq.com
42. INSERM: Causes mèdicales de dècès. Annèe 1991. Rèsultats dèfinitifs.France.
43. Weitzenblum E, Chaouat A, Faller M, Kessler R. L’insuffisance respiratoire chronique: evaluation, èvolution, pronostic. Bull Acad Natle Mèd., 1998; 182:1123-1137.
44. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123(5): 1460-1466.
45. Meyer PA, Manino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest 2002; 122(6): 2003-2008.
46. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vqestbo J, Lange P. Pronostic value of weight change in chronic obstructive pulmonary disease:results from the Copenhagen City Heart Study. Eur Respir J 2002; 20(3):539-544.
47. Marquis K, Debigare R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(6): 809-813.
48. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 167(4): 544-549.
49. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, Anto JM. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(5):680-685.
50. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD, Ambulatory Care Quality Improvement Project Investigators. Using quality of life to predict hospitalisation and mortality in patients with obstructive lung diseases. Chest 2002; 122(2): 429-436.
51. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002; 47(10): 1148-1149.